Syneos Health Balance Sheet Health
Financial Health criteria checks 3/6
Syneos Health has a total shareholder equity of $3.5B and total debt of $2.7B, which brings its debt-to-equity ratio to 75.8%. Its total assets and total liabilities are $8.1B and $4.6B respectively. Syneos Health's EBIT is $342.8M making its interest coverage ratio 3.1. It has cash and short-term investments of $91.2M.
Key information
75.8%
Debt to equity ratio
US$2.65b
Debt
| Interest coverage ratio | 3.1x |
| Cash | US$91.17m |
| Equity | US$3.49b |
| Total liabilities | US$4.58b |
| Total assets | US$8.08b |
Recent financial health updates
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03Financial Position Analysis
Short Term Liabilities: SYNH's short term assets ($2.0B) exceed its short term liabilities ($1.6B).
Long Term Liabilities: SYNH's short term assets ($2.0B) do not cover its long term liabilities ($3.0B).
Debt to Equity History and Analysis
Debt Level: SYNH's net debt to equity ratio (73.2%) is considered high.
Reducing Debt: SYNH's debt to equity ratio has reduced from 101.8% to 75.8% over the past 5 years.
Debt Coverage: SYNH's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: SYNH's interest payments on its debt are well covered by EBIT (3.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/09/29 07:59 |
| End of Day Share Price | 2023/09/27 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Syneos Health, Inc. is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Bolan | Avondale Partners |
| Eric Coldwell | Baird |
| Stewart Glickman | CFRA Equity Research |